Comparison of constituents, antioxidant potency, and acetylcholinesterase inhibition in Lentinus edodes, Sparassis crispa, and Mycoleptodonoides aitchisonii

Food Science and Biotechnology

Volumn 22, Issue 6, 2013, Pages 1747-1751

  Lee, Mi Ra ^a   Hou, Jing Gang ^a   Begum, Shahnaz ^a   Xue, Jian Jie ^a   Wang, Yun Bo ^a   Sung, Chang Keun ^a  

^a Chungnam National University   (South Korea)

Author keywords

acetylcholinesterase; antioxidant potency; Lentinus edodes; Mycoleptodonoides aitchisonii; Sparassi scrispa

Indexed keywords

AMINO ACIDS;

ACETYLCHOLINESTERASE; ACETYLCHOLINESTERASE INHIBITION; ESSENTIAL AMINO ACIDS; LENTINUS EDODES; MYCOLEPTODONOIDES AITCHISONII; PHENOLIC CONTENT; SCAVENGING ACTIVITIES; SPARASSI SCRISPA;

ANTIOXIDANTS;

EID: 84890919831     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10068-013-0276-5     Document Type: Article

References (24)

1. Agrahar-Murugkar D, Subbulakshmi G. Nutritional value of edible wild mushrooms collected from the Khasi hills of Meghalaya. Food Chem. 89: 599-603 (2005).
2. Lindequist U, Niedermeyer THJ, Julich WD. The pharmacological potential of mushrooms. Evid-Based Compl. Alt. 2: 285-299 (2005).
3. Cummings JL, Kaufer D. Neuropsychiatric aspects of Alzheimer's disease: The cholinergic hypothesis revisited. Neurology 47: 876-883 (1996).
4. Bartus RT. On neurodegenerative disease, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp. Neurol. 163: 495-529 (2000).
5. Fernstrom JD. Aromatic amino acids and monoamine synthesis in the central nervous system: Influence of the diet. J. Nutr. Biochem. 1: 508-517 (1990).
6. Yokogoshi H, Roberts CH, Caballero B, Wurtman RJ. Effect of aspartame and glucose administration on brain and plasma levels of large neutral amino acids and brain 5-hydroxyindoles. Am. J. Clin. Nutr. 40: 1-7 (1984).
7. Yasukawa K, Kanno H, Kaminaga T, Takido M, Kasahara Y, Kumaki K. Inhibitory effect of methanol extracts from edible mushroom on TPA-induced ear oedema and tumour promotion in mouse skin. Phytother. Res. 10: 367-369 (1996).
8. Taguchi T, Furue H, Kimura T, Kondo T, Hattori T, Ogata N. Clinical efcacy of lentinan on neoplastic diseases. Adv. Exp. Med. Biol. 166: 181-187 (1983).
9. Ohno N, Miura NN, Nakajima M, Yadomae T. Antitumor 1, 3-β-glican from cultured fruit body of Sparassis crispa. Biol. Pharm. Bull. 1: 866-872 (2000).
10. Sato T, Takeuchi A, Ishida T, Obara K, Hirose T, Takai K, Fujino K, Sakamoto Y. Antihypertensive effect of an aqueous extract from fruit body of Mycoleptodonoides aitchisonii in spontaneously hypertensive rats. Oyo Yakuri. Pharmacometrics 61: 177-183 (2001).
11. Okuyama S, Terashima T, Kawamura Y, Yokogoshi H. Enhancing effect of Mycoleptodonoides aitchisonii on synthesis of nerve growth factor and releasing dopamine in the rat brain. Nutr. Neurosci. 7: 41-47 (2004).
12. Okuyama S, Tashiro K, Lam NV, Hatakeyama T, Terashima T, Yokogoshi H. Effect of the edible mushroom Mycoleptodonoides aitchisonii on transient global ischemia-induced monoamine metabolism changes in rat cerebral cortex. J. Med. Food. 15: 96-99 (2012).
13. Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic phosphotungistic acid reagents. Am. J. Enol. Viticult. 16: 144-158 (1965).
14. Blois MS. Antioxidant determinations by the use of as table free radical. Nature 181: 1199-1202 (1958).
15. Ellman GL, Courtney KD, Andres JrV, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7: 88-95 (1961).
16. Mau JL, Lin HC, Chen CC. Non-volatile components of several medicinal mushrooms. Food Res. Int. 34: 521-526 (2001).
17. Chen XH, Xia LX, Zhou HB, Qiu GZ. Chemical composition and antioxidant activities of Russula griseocarnosa sp. nov. J. Agr. Food Chem. 58: 6966-6971 (2010).
18. Cheung LM, Cheung PCK. Mushroom extracts with antioxidant activity against lipid peroxidation. Food Chem. 89: 403-409 (2005).
19. Yen GC, Wu JY. Antioxidant and radical scavenging properties of extracts from Ganoderma tsugae. Food Chem. 65: 375-379 (1993).
20. Darreh-Shori T, Soininen H. Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent clinical studies. Curr. Alzheimer Res. 7: 67-73 (2010).
21. Hatano T, Edamatsu R, Hiramatsu M, Mori M, Fujita Y, Yasuhara T, Uoshida T, Okuda T. Effects of the interaction of tannins with coexisting substances. VI: Effects of tannins and related polyphenols on superoxide anion radical, and on 1, 1-diphenyl-2-picrylhydrazyl radical. Chem. Pharm. Bull. 7: 2016-2021 (1989).
22. van Marum RJ. Current and future therapy in Alzheimer's disease. Fund. Clin. Pharmacol. 22: 265-274 (2008).
23. Hornick A, Schwaiger S, Rollinger JM, Vo NP, Prast H, Stuppner H. Extracts and constituents of Leontopodium alpinum enhance cholinergic transmission: Brain ACh increasing and memory improving properties. Biochem. Pharmacol. 76: 236-248 (2008).
24. Yokogoshi H. Effect of dietary level of protein or methionine and threonine on the amino acids and catecholamines in brain of rats fed a high tyrosine diet. J. Nutr. Sci. Vitaminol. 31: 519-531 (1985).